405 related articles for article (PubMed ID: 26784676)
1. Reduced numbers of mucosal DR(int) macrophages and increased numbers of CD103(+) dendritic cells during anti-TNF-α treatment in patients with Crohn's disease.
Dige A; Magnusson MK; Öhman L; Hvas CL; Kelsen J; Wick MJ; Agnholt J
Scand J Gastroenterol; 2016; 51(6):692-9. PubMed ID: 26784676
[TBL] [Abstract][Full Text] [Related]
2. Macrophage and dendritic cell subsets in IBD: ALDH+ cells are reduced in colon tissue of patients with ulcerative colitis regardless of inflammation.
Magnusson MK; Brynjólfsson SF; Dige A; Uronen-Hansson H; Börjesson LG; Bengtsson JL; Gudjonsson S; Öhman L; Agnholt J; Sjövall H; Agace WW; Wick MJ
Mucosal Immunol; 2016 Jan; 9(1):171-82. PubMed ID: 26080709
[TBL] [Abstract][Full Text] [Related]
3. Increased production of retinoic acid by intestinal macrophages contributes to their inflammatory phenotype in patients with Crohn's disease.
Sanders TJ; McCarthy NE; Giles EM; Davidson KL; Haltalli ML; Hazell S; Lindsay JO; Stagg AJ
Gastroenterology; 2014 May; 146(5):1278-88.e1-2. PubMed ID: 24503130
[TBL] [Abstract][Full Text] [Related]
4. Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease.
Ogino T; Nishimura J; Barman S; Kayama H; Uematsu S; Okuzaki D; Osawa H; Haraguchi N; Uemura M; Hata T; Takemasa I; Mizushima T; Yamamoto H; Takeda K; Doki Y; Mori M
Gastroenterology; 2013 Dec; 145(6):1380-91.e1. PubMed ID: 23993972
[TBL] [Abstract][Full Text] [Related]
5. Anti-Tumor Necrosis Factor With a Glyco-Engineered Fc-Region Has Increased Efficacy in Mice With Colitis.
Bloemendaal FM; Levin AD; Wildenberg ME; Koelink PJ; McRae BL; Salfeld J; Lum J; van der Neut Kolfschoten M; Claassens JW; Visser R; Bentlage A; D'Haens GRAM; Verbeek JS; Vidarsson G; van den Brink GR
Gastroenterology; 2017 Nov; 153(5):1351-1362.e4. PubMed ID: 28756234
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of alpha E beta 7 integrin on intra-epithelial and lamina propria lymphocytes in patients with Crohn's disease.
Elewaut D; Van Damme N; De Keyser F; Baeten D; De Paepe P; Van Vlierberghe H; Mielants H; Cuvelier C; Verbruggen G; Veys EM; De Vos M
Acta Gastroenterol Belg; 1998; 61(3):288-94. PubMed ID: 9795455
[TBL] [Abstract][Full Text] [Related]
7. A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity.
Fujimoto K; Karuppuchamy T; Takemura N; Shimohigoshi M; Machida T; Haseda Y; Aoshi T; Ishii KJ; Akira S; Uematsu S
J Immunol; 2011 Jun; 186(11):6287-95. PubMed ID: 21525388
[TBL] [Abstract][Full Text] [Related]
8. Mucosal expression of basic fibroblastic growth factor, syndecan 1 and tumour necrosis factor-α in Crohn's disease in deep remission under treatment with anti-TNFα antibodies.
Tursi A; Elisei W; Principi M; Inchingolo CD; Nenna R; Picchio M; Giorgio F; Ierardi E; Brandimarte G
J Gastrointestin Liver Dis; 2014 Sep; 23(3):261-5. PubMed ID: 25267953
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic response to tumor necrosis factor inhibitors predicts long term benefits in Crohn's disease.
Alfaro I; Masamunt MC; Planell N; López-García A; Castro J; Gallego M; Barastegui R; Giner A; Vara A; Salas A; Ricart E; Panés J; Ordás I
World J Gastroenterol; 2019 Apr; 25(14):1764-1774. PubMed ID: 31011260
[TBL] [Abstract][Full Text] [Related]
10. CD103+ Dendritic Cell Function Is Altered in the Colons of Patients with Ulcerative Colitis.
Matsuno H; Kayama H; Nishimura J; Sekido Y; Osawa H; Barman S; Ogino T; Takahashi H; Haraguchi N; Hata T; Matsuda C; Yamamoto H; Uchino M; Ikeuchi H; Doki Y; Mori M; Takeda K; Mizushima T
Inflamm Bowel Dis; 2017 Sep; 23(9):1524-1534. PubMed ID: 28700533
[TBL] [Abstract][Full Text] [Related]
11. Flt3 ligand expands CD103⁺ dendritic cells and FoxP3⁺ T regulatory cells, and attenuates Crohn's-like murine ileitis.
Collins CB; Aherne CM; McNamee EN; Lebsack MD; Eltzschig H; Jedlicka P; Rivera-Nieves J
Gut; 2012 Aug; 61(8):1154-62. PubMed ID: 22068168
[TBL] [Abstract][Full Text] [Related]
12. Effect of tumor necrosis factor-α blockade on mucosal addressin cell-adhesion molecule-1 in Crohn's disease.
Biancheri P; Di Sabatino A; Rovedatti L; Giuffrida P; Calarota SA; Vetrano S; Vidali F; Pasini A; Danese S; Corazza GR; MacDonald TT
Inflamm Bowel Dis; 2013 Feb; 19(2):259-64. PubMed ID: 23328772
[TBL] [Abstract][Full Text] [Related]
13. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
14. Characterization of ileal dendritic cell distribution in a rat model of acute and chronic inflammation.
Silva MA; Porras M; Jury J; Vergara P; Perdue MH
Inflamm Bowel Dis; 2006 Jun; 12(6):457-70. PubMed ID: 16775489
[TBL] [Abstract][Full Text] [Related]
15. Higher Adalimumab Drug Levels are Associated with Mucosal Healing in Patients with Crohn's Disease.
Zittan E; Kabakchiev B; Milgrom R; Nguyen GC; Croitoru K; Steinhart AH; Silverberg MS
J Crohns Colitis; 2016 May; 10(5):510-5. PubMed ID: 26783345
[TBL] [Abstract][Full Text] [Related]
16. A subset of human dendritic cells in the T cell area of mucosa-associated lymphoid tissue with a high potential to produce TNF-alpha.
de Baey A; Mende I; Baretton G; Greiner A; Hartl WH; Baeuerle PA; Diepolder HM
J Immunol; 2003 May; 170(10):5089-94. PubMed ID: 12734354
[TBL] [Abstract][Full Text] [Related]
17. CD14(hi)HLA-DR(dim) macrophages, with a resemblance to classical blood monocytes, dominate inflamed mucosa in Crohn's disease.
Thiesen S; Janciauskiene S; Uronen-Hansson H; Agace W; Högerkorp CM; Spee P; Håkansson K; Grip O
J Leukoc Biol; 2014 Mar; 95(3):531-41. PubMed ID: 24212097
[TBL] [Abstract][Full Text] [Related]
18. TGR5 signalling inhibits the production of pro-inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's disease.
Yoneno K; Hisamatsu T; Shimamura K; Kamada N; Ichikawa R; Kitazume MT; Mori M; Uo M; Namikawa Y; Matsuoka K; Sato T; Koganei K; Sugita A; Kanai T; Hibi T
Immunology; 2013 May; 139(1):19-29. PubMed ID: 23566200
[TBL] [Abstract][Full Text] [Related]
19. Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells.
Iliev ID; Spadoni I; Mileti E; Matteoli G; Sonzogni A; Sampietro GM; Foschi D; Caprioli F; Viale G; Rescigno M
Gut; 2009 Nov; 58(11):1481-9. PubMed ID: 19570762
[TBL] [Abstract][Full Text] [Related]
20. Role of the advanced glycation end products receptor in Crohn's disease inflammation.
Ciccocioppo R; Vanoli A; Klersy C; Imbesi V; Boccaccio V; Manca R; Betti E; Cangemi GC; Strada E; Besio R; Rossi A; Falcone C; Ardizzone S; Fociani P; Danelli P; Corazza GR
World J Gastroenterol; 2013 Dec; 19(45):8269-81. PubMed ID: 24363518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
